Predictive Oncology aims to enhance drug discovery using its biobank and AI, following industry trends exemplified by Regeneron's 23andMe acquisition. Predictive Oncology Inc. is leveraging its ...
Use of FLIM histology-based HER2-HER3 heterodimer quantification and a Bayesian latent class proportional hazards model to predict cetuximab response in the COIN and new EPOC trials. Retrospective ...
Feasibility of long-term patient reporting of toxicities from home via the internet during routine chemotherapy. The importance of early treatment to decrease therapy-related complications in Burkitt ...
Increasing LACE+ index score is a significant predictor of greater risk of unplanned readmission, emergency department visits, and reoperation after gynecologic surgery. ABSTRACTObjectives: Assessment ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results